New use possible for Lilly’s Evista
Eli Lilly and Co. may have found a new use for its osteoporosis drug Evista, according to Bloomberg. The U.S. Food and Drug Administration said Evista reduced the risk of certain invasive breast cancers in post-menopausal women. However, studies from Indianapolis-based Lilly provided weaker support for Evista’s ability to help women at high risk of […]